BBOT Stock Slides as Investors Price a Smaller Opportunity

BBOT dropped ~38% in two days. Stifel, Leerink, Canaccord, and JPMorgan lowered targets but did not downgrade ratings. JPMorgan sees a disconnect vs pipeline value.

BBOT Stock Slides as Investors Price a Smaller Opportunity
Credit: BridgeBio Oncology Therapeutics
Already have an account? Sign in.